Post-FDA Approval Results of Epithelium-Off, Full-Fluence, Dresden Protocol Corneal Collagen Crosslinking in the USA

INTRODUCTION: The purpose of this non-comparative, prospective, observational study was to evaluate the post-US Food and Drug Administration approval outcomes of epithelium-off, full-fluence, Dresden protocol corneal collagen crosslinking (CXL) for the treatment of progressive keratoconus (KCN) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ansah, Derick O., Wang, Jiangxia, Lu, Kevin, Jabbour, Samir, Bower, Kraig S., Soiberman, Uri S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708565/
https://www.ncbi.nlm.nih.gov/pubmed/33029700
http://dx.doi.org/10.1007/s40123-020-00306-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708565/
https://www.ncbi.nlm.nih.gov/pubmed/33029700
http://dx.doi.org/10.1007/s40123-020-00306-1

Ejemplares similares